• Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

    Source: Nasdaq GlobeNewswire / 19 Oct 2023 07:30:00   America/New_York

    N/A
Share on,